Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.

Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Lippman SM, Klein EA.

J Natl Cancer Inst. 2014 Mar;106(3):djt456. doi: 10.1093/jnci/djt456. Epub 2014 Feb 22.

2.

Advanced prostate cancer risk in relation to toenail selenium levels.

Geybels MS, Verhage BA, van Schooten FJ, Goldbohm RA, van den Brandt PA.

J Natl Cancer Inst. 2013 Sep 18;105(18):1394-401. doi: 10.1093/jnci/djt186. Epub 2013 Jul 22.

PMID:
23878355
3.

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LH.

JAMA. 2011 Oct 12;306(14):1549-56. doi: 10.1001/jama.2011.1437.

4.

Prostate cancer: new data on risks of selenium and vitamin E.

Payton S.

Nat Rev Urol. 2014 Apr;11(4):184. doi: 10.1038/nrurol.2014.58. Epub 2014 Mar 11. No abstract available.

PMID:
24619375
5.

Baseline selenium and prostate cancer risk: comments and open questions.

Frankel PH, Parker RS, Madsen FC, Whanger PD.

J Natl Cancer Inst. 2014 Mar;106(3):dju005. doi: 10.1093/jnci/dju005. Epub 2014 Feb 22. No abstract available.

6.

Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Klein EA, Kristal AR.

J Natl Cancer Inst. 2013 Aug 7;105(15):1132-41. doi: 10.1093/jnci/djt174. Epub 2013 Jul 10.

7.

Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Barrington WE, Schenk JM, Etzioni R, Arnold KB, Neuhouser ML, Thompson IM Jr, Lucia MS, Kristal AR.

JAMA Oncol. 2015 Jun;1(3):342-9. doi: 10.1001/jamaoncol.2015.0513. Erratum in: JAMA Oncol. 2015 Jun;1(3):322.

8.

Moving a randomized clinical trial into an observational cohort.

Goodman PJ, Hartline JA, Tangen CM, Crowley JJ, Minasian LM, Klein EA, Cook ED, Darke AK, Arnold KB, Anderson K, Yee M, Meyskens FL, Baker LH.

Clin Trials. 2013 Feb;10(1):131-42. doi: 10.1177/1740774512460345. Epub 2012 Oct 12.

9.

Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.

Kirsh VA, Hayes RB, Mayne ST, Chatterjee N, Subar AF, Dixon LB, Albanes D, Andriole GL, Urban DA, Peters U; PLCO Trial.

J Natl Cancer Inst. 2006 Feb 15;98(4):245-54.

PMID:
16478743
10.

Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study.

van den Brandt PA, Zeegers MP, Bode P, Goldbohm RA.

Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):866-71.

11.

Vitamin E and prostate cancer: research focus turns to biologic mechanisms.

McNeil C.

J Natl Cancer Inst. 2011 Dec 7;103(23):1731-4. doi: 10.1093/jnci/djr504. Epub 2011 Nov 18. No abstract available.

PMID:
22100581
13.

Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial.

Christen WG, Glynn RJ, Gaziano JM, Darke AK, Crowley JJ, Goodman PJ, Lippman SM, Lad TE, Bearden JD, Goodman GE, Minasian LM, Thompson IM Jr, Blanke CD, Klein EA.

JAMA Ophthalmol. 2015 Jan;133(1):17-24. doi: 10.1001/jamaophthalmol.2014.3478.

14.

Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials.

Jiang L, Yang KH, Tian JH, Guan QL, Yao N, Cao N, Mi DH, Wu J, Ma B, Yang SH.

Nutr Cancer. 2010;62(6):719-27. doi: 10.1080/01635581.2010.494335.

PMID:
20661819
15.

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr.

JAMA. 2009 Jan 7;301(1):39-51. doi: 10.1001/jama.2008.864. Epub 2008 Dec 9.

16.

Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?

Moyad MA.

Urology. 2002 Apr;59(4 Suppl 1):9-19. Review.

PMID:
11937432
17.

Vitamin E and C supplementation and risk of cancer in men: posttrial follow-up in the Physicians' Health Study II randomized trial.

Wang L, Sesso HD, Glynn RJ, Christen WG, Bubes V, Manson JE, Buring JE, Gaziano JM.

Am J Clin Nutr. 2014 Sep;100(3):915-23. doi: 10.3945/ajcn.114.085480. Epub 2014 Jul 9.

18.

Selenium and prostate cancer prevention: insights from the selenium and vitamin E cancer prevention trial (SELECT).

Nicastro HL, Dunn BK.

Nutrients. 2013 Apr 3;5(4):1122-48. doi: 10.3390/nu5041122. Review.

19.

Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.

Kristal AR, Till C, Song X, Tangen CM, Goodman PJ, Neuhauser ML, Schenk JM, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Klein EA.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1494-504. doi: 10.1158/1055-9965.EPI-14-0115. Epub 2014 Apr 14.

20.

Selenium for preventing cancer.

Vinceti M, Dennert G, Crespi CM, Zwahlen M, Brinkman M, Zeegers MP, Horneber M, D'Amico R, Del Giovane C.

Cochrane Database Syst Rev. 2014 Mar 30;(3):CD005195. doi: 10.1002/14651858.CD005195.pub3. Review.

Supplemental Content

Support Center